Location History:
- Riverside, CA (US) (2012)
- Ewing, PA (US) (2013)
Company Filing History:
Years Active: 2012-2013
Title: Shih-hsin Kan: Innovator in Inflammatory Bowel Disease Research
Introduction
Shih-hsin Kan is a prominent inventor based in Ewing, PA (US), known for her significant contributions to the field of medical diagnostics. With a focus on inflammatory bowel diseases, she has developed innovative methods that enhance the understanding and prediction of these conditions. Her work has led to the filing of two patents, showcasing her commitment to advancing medical science.
Latest Patents
Shih-hsin Kan's latest patents include groundbreaking research on splice variants of the human IL-23 receptor (IL-23R) mRNA. This research involves the cloning and identification of human IL-23R splice variants caused by alternative splicing of the IL-23R mRNA. A total of twenty-five different IL-23R transcripts were identified, including a novel exon deletion isoform, denoted as Δ9. This isoform is predominantly present in colon and cervical tissues, and a decrease in Δ9 is observed in inflamed colon tissues in Crohn's patients. The patents also describe a quantitative assay to measure different IL-23R isoforms and a method for predicting Crohn's disease by measuring the Δ9 isoform of IL-23R.
Career Highlights
Shih-hsin Kan is currently employed at Medical Diagnostic Laboratories, LLC, where she continues to push the boundaries of medical research. Her work is instrumental in developing diagnostic tools that can significantly impact patient care and treatment options for inflammatory bowel diseases.
Collaborations
Shih-hsin Kan collaborates with notable colleagues, including Raymond Yu and Giacomo Mancini, to further her research initiatives. These collaborations enhance the depth and breadth of her work, contributing to the advancement of medical diagnostics.
Conclusion
Shih-hsin Kan's innovative research and patents in the field of inflammatory bowel diseases exemplify her dedication to improving medical diagnostics. Her contributions are paving the way for better understanding and treatment of these complex conditions.